Cover Image
市場調查報告書

川崎病:全球臨床實驗檢討

Kawasaki Disease Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318338
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
川崎病:全球臨床實驗檢討 Kawasaki Disease Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 67 Pages
簡介

川崎病是供給心臟血液的冠狀動脈等全身中型動脈壁發炎的狀態。川崎病同時也稱作皮膚粘膜淋巴節症候群,也會影響淋巴節、皮膚、口、鼻、咽喉內側的粘膜。川崎病的症狀有高燒,皮膚剝離等。川崎病一般是可治療的,大多數孩童都不會產生嚴重的問題而得以康復。

本報告提供川崎病的治療藥相關臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段、及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:免疫系臨床實驗上川崎病所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:免疫系臨床實驗上川崎病所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對像

贊助商類別臨床實驗

有潛力的贊助商

  • 川崎病的治療藥臨床實驗的主要參與企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Bristol-Myers Squibb Company
    • 三菱Chemical Holdings Corporation
    • Hawaii Pacific Health
    • Green Cross Holdings Corporation
    • Bio Products Laboratory Ltd.
    • Baxter International Inc.
  • 主要大學·研究機關·醫院臨床實驗概要
    • University of California, San Diego
    • 東京東京都立兒童綜合醫療中心
    • National Heart, Lung, and Blood Institute
    • 東邦大學
    • 琦玉醫科大學
    • 自治醫科大學
    • Pontificia Universidad Catolica de Chile
    • University of Leeds
    • 日本大學
    • University of Nebraska

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2383CTIDB

GlobalData's clinical trial report, "Kawasaki Disease Global Clinical Trials Review, H2, 2014" provides data on the Kawasaki Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kawasaki Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Kawasaki Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Kawasaki Disease
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Kawasaki Disease to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Kawasaki Disease to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Kawasaki Disease
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Kawasaki Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Mitsubishi Chemical Holdings Corporation
      • Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation
      • Hawaii Pacific Health
      • Clinical Trial Overview of Hawaii Pacific Health
      • Green Cross Holdings Corporation
      • Clinical Trial Overview of Green Cross Holdings Corporation
      • Bio Products Laboratory Ltd.
      • Clinical Trial Overview of Bio Products Laboratory Ltd.
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • University of California, San Diego
      • Clinical Trial Overview of University of California, San Diego
      • Tokyo Metropolitan Children's Medical Center
      • Clinical Trial Overview of Tokyo Metropolitan Children's Medical Center
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Toho University
      • Clinical Trial Overview of Toho University
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • Jichi Medical University
      • Clinical Trial Overview of Jichi Medical University
      • Pontificia Universidad Catolica de Chile
      • Clinical Trial Overview of Pontificia Universidad Catolica de Chile
      • University of Leeds
      • Clinical Trial Overview of University of Leeds
      • Nihon University
      • Clinical Trial Overview of Nihon University
      • University of Nebraska
      • Clinical Trial Overview of University of Nebraska
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Kawasaki Disease Therapeutics, Global, Clinical Trials by Region, 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Kawasaki Disease to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Kawasaki Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Kawasaki Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Kawasaki Disease to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Kawasaki Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Kawasaki Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Kawasaki Disease Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Kawasaki Disease Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Kawasaki Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Chemical Holdings Corporation, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hawaii Pacific Health, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Holdings Corporation, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio Products Laboratory Ltd., 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Metropolitan Children's Medical Center, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Toho University, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Jichi Medical University, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pontificia Universidad Catolica de Chile, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leeds, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014*

List of Figures

  • Kawasaki Disease Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Kawasaki Disease to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Kawasaki Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Kawasaki Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Kawasaki Disease to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Kawasaki Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Kawasaki Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Kawasaki Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Kawasaki Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Kawasaki Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top